Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RICAMIS: Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke
NCT03740971Completed
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Dec 2018
- Primary completion
- Apr 2021
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Proportion of patients with mRS 0-1 at 90 days. Started Dec 2018; status: completed.
Beyond the preview
Go deeper on NCT03740971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03740971.